journal
Journals MMWR. Morbidity and Mortality ...

MMWR. Morbidity and Mortality Weekly Report

https://read.qxmd.com/read/38635498/quickstats-percentage-of-children-and-adolescents-aged-3-17-years-who-ever-received-a-diagnosis-of-autism-spectrum-disorder-%C3%A2-by-family-income-%C3%A2-2020-2022
#1
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 18, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38635488/use-of-the-pfizer-pentavalent-meningococcal-vaccine-among-persons-aged-%C3%A2-10-years-recommendations-of-the-advisory-committee-on-immunization-practices-united-states-2023
#2
JOURNAL ARTICLE
Jennifer P Collins, Samuel J Crowe, Ismael R Ortega-Sanchez, Lynn Bahta, Doug Campos-Outcalt, Jamie Loehr, Rebecca L Morgan, Katherine A Poehling, Lucy A McNamara
Meningococcal disease is a life-threatening invasive infection caused by Neisseria meningitidis. Two quadrivalent (serogroups A, C, W, and Y) meningococcal conjugate vaccines (MenACWY) (MenACWY-CRM [Menveo, GSK] and MenACWY-TT [MenQuadfi, Sanofi Pasteur]) and two serogroup B meningococcal vaccines (MenB) (MenB-4C [Bexsero, GSK] and MenB-FHbp [Trumenba, Pfizer Inc.]), are licensed and available in the United States and have been recommended by CDC's Advisory Committee on Immunization Practices (ACIP). On October 20, 2023, the Food and Drug Administration approved the use of a pentavalent meningococcal vaccine (MenACWY-TT/MenB-FHbp [Penbraya, Pfizer Inc...
April 18, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38635484/heat-related-emergency-department-visits-united-states-may-september-2023
#3
JOURNAL ARTICLE
Ambarish Vaidyanathan, Abigail Gates, Claudia Brown, Emily Prezzato, Aaron Bernstein
Unprecedented heat waves can affect all persons, but some are more sensitive to the effects of heat, including children and adults with underlying health conditions, pregnant women, and outdoor workers. Many regions of the United States experienced record-breaking high temperatures in 2023, with populations exposed to extremely high temperatures for prolonged periods. CDC examined emergency department (ED) visits associated with heat-related illness (HRI) from the National Syndromic Surveillance Program and compared daily HRI ED visit rates during the warm-season months (May-September) of 2023 with those during 2018-2022...
April 18, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38635481/durability-of-original-monovalent-mrna-vaccine-effectiveness-against-covid-19-omicron-associated-hospitalization-in-children-and-adolescents-united-states-2021-2023
#4
JOURNAL ARTICLE
Laura D Zambrano, Margaret M Newhams, Regina M Simeone, Amanda B Payne, Michael Wu, Amber O Orzel-Lockwood, Natasha B Halasa, Jemima M Calixte, Pia S Pannaraj, Kanokporn Mongkolrattanothai, Julie A Boom, Leila C Sahni, Satoshi Kamidani, Kathleen Chiotos, Melissa A Cameron, Aline B Maddux, Katherine Irby, Jennifer E Schuster, Elizabeth H Mack, Austin Biggs, Bria M Coates, Kelly N Michelson, Katherine E Bline, Ryan A Nofziger, Hillary Crandall, Charlotte V Hobbs, Shira J Gertz, Sabrina M Heidemann, Tamara T Bradford, Tracie C Walker, Stephanie P Schwartz, Mary Allen Staat, Samina S Bhumbra, Janet R Hume, Michele Kong, Melissa S Stockwell, Thomas J Connors, Melissa L Cullimore, Heidi R Flori, Emily R Levy, Natalie Z Cvijanovich, Matt S Zinter, Mia Maamari, Cindy Bowens, Danielle M Zerr, Judith A Guzman-Cottrill, Ivan Gonzalez, Angela P Campbell, Adrienne G Randolph
Pediatric COVID-19 vaccination is effective in preventing COVID-19-related hospitalization, but duration of protection of the original monovalent vaccine during SARS-CoV-2 Omicron predominance merits evaluation, particularly given low coverage with updated COVID-19 vaccines. During December 19, 2021-October 29, 2023, the Overcoming COVID-19 Network evaluated vaccine effectiveness (VE) of ≥2 original monovalent COVID-19 mRNA vaccine doses against COVID-19-related hospitalization and critical illness among U...
April 18, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38635474/covid-19-vaccination-coverage-and-rates-of-sars-cov-2-infection-and-covid-19-associated-hospitalization-among-residents-in-nursing-homes-national-healthcare-safety-network-united-states-october-2023-february-2024
#5
JOURNAL ARTICLE
David Franklin, Kira Barbre, Theresa A Rowe, Hannah E Reses, Jason Massey, Lu Meng, Philip Dollard, Heather Dubendris, Molly Stillions, Lindsay Robinson, Jacques W Clerville, Kara Jacobs Slifka, Andrea Benin, Jeneita M Bell
Nursing home residents are at increased risk for developing severe COVID-19. Nursing homes report weekly facility-level data on SARS-CoV-2 infections, COVID-19-associated hospitalizations, and COVID-19 vaccination coverage among residents to CDC's National Healthcare Safety Network. This analysis describes rates of incident SARS-CoV-2 infection, rates of incident COVID-19-associated hospitalization, and COVID-19 vaccination coverage during October 16, 2023-February 11, 2024. Weekly rates of SARS-CoV-2 infection ranged from 61...
April 18, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38602895/infections-associated-with-medtronic-duet-external-ventricular-drains-rhode-island-hospital-providence-rhode-island-january-2023-january-2024
#6
JOURNAL ARTICLE
Kevin M Gibas, Dianne Auld, Stephanie Parente, Jean Horoho, Leonard A Mermel
External ventricular drains (EVDs) are medical devices that are inserted into the ventricles of the brain to drain excess fluid, manage intracranial hypertension, monitor intracranial pressure, and administer medications. Unintentional disconnections and breaks or fractures (breaks) of EVDs or associated drainage system components can result in cerebrospinal fluid (CSF) leakage and increased risk for EVD-associated infections. After replacement of Integra Life Sciences EVD systems with Medtronic Duet EVD systems at Rhode Island Hospital in mid-September 2023, a threefold increase was observed in the prevalence of positive CSF cultures, from 2...
April 11, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38602891/notes-from-the-field-neonatal-salmonellosis-associated-with-backyard-poultry-oregon-november-2023
#7
JOURNAL ARTICLE
Stephen G Ladd-Wilson, Karen Yeargain, Samuel P Myoda, Mansour Samadpour, Karim Morey, Paul R Cieslak
No abstract text is available yet for this article.
April 11, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38602888/assessment-of-risk-for-sudden-cardiac-death-among-adolescents-and-young-adults-after-receipt-of-covid-19-vaccine-oregon-june-2021-december-2022
#8
JOURNAL ARTICLE
Juventila Liko, Paul R Cieslak
COVID-19 vaccination has been associated with myocarditis in adolescents and young adults, and concerns have been raised about possible vaccine-related cardiac fatalities in this age group. In April 2021, cases of myocarditis after COVID-19 vaccination, particularly among young male vaccine recipients, were reported to the Vaccine Adverse Event Reporting System. To assess this possibility, investigators searched death certificates for Oregon residents aged 16-30 years who died during June 2021-December 2022 for cardiac or undetermined causes of death...
April 11, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38602886/measles-united-states-january-1-2020-march-28-2024
#9
JOURNAL ARTICLE
Adria D Mathis, Kelley Raines, Nina B Masters, Thomas D Filardo, Gimin Kim, Stephen N Crooke, Bettina Bankamp, Paul A Rota, David E Sugerman
Measles is a highly infectious febrile rash illness and was declared eliminated in the United States in 2000. However, measles importations continue to occur, and U.S. measles elimination status was threatened in 2019 as the result of two prolonged outbreaks among undervaccinated communities in New York and New York City. To assess U.S. measles elimination status after the 2019 outbreaks and to provide context to understand more recent increases in measles cases, CDC analyzed epidemiologic and laboratory surveillance data and the performance of the U...
April 11, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38602885/state-medicaid-coverage-for-tobacco-cessation-treatments-and-barriers-to-accessing-treatments-united-states-2018-2022
#10
JOURNAL ARTICLE
Anne DiGiulio, Michael A Tynan, Anna Schecter, Kisha-Ann S Williams, Brenna VanFrank
The prevalence of cigarette smoking among U.S. adults enrolled in Medicaid is higher than among adults with private insurance; more than one in five adults enrolled in Medicaid smokes cigarettes. Smoking cessation reduces the risk for smoking-related disease and death. Effective treatments for smoking cessation are available, and comprehensive, barrier-free insurance coverage of these treatments can increase cessation. However, Medicaid treatment coverage and treatment access barriers vary by state. The American Lung Association collected and analyzed state-level information regarding coverage for nine tobacco cessation treatments and seven access barriers for standard Medicaid enrollees...
April 11, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38602879/covid-19-vaccination-coverage-world-health-organization-african-region-2021-2023
#11
JOURNAL ARTICLE
Reena H Doshi, Sheillah Nsasiirwe, Melissa Dahlke, Ajiri Atagbaza, Oniovo Efe Aluta, Alain Blaise Tatsinkou, Ezekiel Dauda, Alba Vilajeliu, Santosh Gurung, Jayne Tusiime, Fiona Braka, Ado Bwaka, Sarah Wanyoike, Donald J Brooks, Diana Chang Blanc, James P Alexander, Benjamin A Dahl, Ann Lindstrand, Charles S Wiysonge
With the availability of authorized COVID-19 vaccines in early 2021, vaccination became an effective tool to reduce COVID-19-associated morbidity and mortality. Initially, the World Health Organization (WHO) set an ambitious target to vaccinate 70% of the global population by mid-2022. However, in July 2022, WHO recommended that all countries, including those in the African Region, prioritize COVID-19 vaccination of high-risk groups, including older adults and health care workers, to have the greatest impact on morbidity and mortality...
April 11, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38573875/notice-to-readers-change-in-publication-date-of-quickstats
#12
(no author information available yet)
No abstract text is available yet for this article.
April 4, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38573869/quickstats-life-expectancy-at-birth-by-sex-%C3%A2-united-states-2019-2022
#13
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 4, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38573867/erratum-vol-71-no-19
#14
(no author information available yet)
No abstract text is available yet for this article.
April 4, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38573866/federal-retail-pharmacy-program-contributions-to-bivalent-mrna-covid-19-vaccinations-across-sociodemographic-characteristics-united-states-september-1-2022-september-30-2023
#15
JOURNAL ARTICLE
Roua El Kalach, Nkenge Jones-Jack, Mattie A Elam, Abdulhakeem Olorukooba, Marley Vazquez, Shannon Stokley, Sarah Meyer, Sunanda McGarvey, Kimvy Nguyen, Lynn Gibbs Scharf, LaTreace Q Harris, Christopher Duggar, Lori B Moore
The Federal Retail Pharmacy Program (FRPP) facilitated integration of pharmacies as partners in national efforts to scale up vaccination capacity during the COVID-19 pandemic emergency response. To evaluate FRPP's contribution to vaccination efforts across various sociodemographic groups, data on COVID-19 bivalent mRNA vaccine doses administered during September 1, 2022-September 30, 2023, were evaluated from two sources: 1) FRPP data reported directly to CDC and 2) jurisdictional immunization information systems data reported to CDC from all 50 states, the District of Columbia, U...
April 4, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38573841/surveillance-to-track-progress-toward-polio-eradication-worldwide-2022-2023
#16
JOURNAL ARTICLE
Nishant Kishore, Elizabeth Krow-Lucal, Ousmane M Diop, Jaume Jorba, Tigran Avagnan, Varja Grabovac, Anfumbom K W Kfutwah, Ticha Johnson, Sudhir Joshi, Lucky Sangal, Salmaan Sharif, Ashraf Wahdan, Graham F Tallis, Stephanie D Kovacs
The reliable and timely detection of poliovirus cases through surveillance for acute flaccid paralysis (AFP), supplemented by environmental surveillance of sewage samples, is a critical component of the polio eradication program. Since 1988, the number of polio cases caused by wild poliovirus (WPV) has declined by >99.9%, and eradication of WPV serotypes 2 and 3 has been certified; only serotype 1 (WPV1) continues to circulate, and transmission remains endemic in Afghanistan and Pakistan. This surveillance update evaluated indicators from AFP surveillance, environmental surveillance for polioviruses, and Global Polio Laboratory Network performance data provided by 28 priority countries for the program during 2022-2023...
April 4, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38547037/interim-effectiveness-of-updated-2023-2024-monovalent-xbb-1-5-covid-19-vaccines-against-covid-19-associated-hospitalization-among-adults-aged-%C3%A2-18-years-with-immunocompromising-conditions-vision-network-september-2023-february-2024
#17
JOURNAL ARTICLE
Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, Kristin Dascomb, Stephanie A Irving, Nicola P Klein, Shaun J Grannis, Toan C Ong, Zachary A Weber, Katherine E Fleming-Dutra, Charlene E McEvoy, Omobosola Akinsete, Daniel Bride, Tamara Sheffield, Allison L Naleway, Ousseny Zerbo, Bruce Fireman, John Hansen, Kristin Goddard, Brian E Dixon, Colin Rogerson, William F Fadel, Thomas Duszynski, Suchitra Rao, Michelle A Barron, Sarah E Reese, Sarah W Ball, Margaret M Dunne, Karthik Natarajan, Erica Okwuazi, Ami B Shah, Ryan Wiegand, Mark W Tenforde, Amanda B Payne
In September 2023, CDC's Advisory Committee on Immunization Practices recommended updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccination for all persons aged ≥6 months to prevent COVID-19, including severe disease. As with past COVID-19 vaccines, additional doses may be considered for persons with immunocompromising conditions, who are at higher risk for severe COVID-19 and might have decreased response to vaccination. In this analysis, vaccine effectiveness (VE) of an updated COVID-19 vaccine dose against COVID-19-associated hospitalization was evaluated during September 2023-February 2024 using data from the VISION VE network...
March 28, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38547036/implications-of-measles-inclusion-by-commercial-syndromic-polymerase-chain-reaction-panels-united-states-may-2022-april-2023
#18
JOURNAL ARTICLE
Christine M Thomas, Amanda Hartley, Ann Schmitz, Heather D Reid, Susan Sullivan, Elise Huebner, Meredith Robinson, Adria Mathis, Mary-Margaret A Fill, Kara J Levinson, Tim F Jones, William Schaffner, Caitlin N Newhouse, John R Dunn
Syndromic polymerase chain reaction (PCR) panels are used to test for pathogens that can cause rash illnesses, including measles. Rash illnesses have infectious and noninfectious causes, and approximately 5% of persons experience a rash 7-10 days after receipt of a measles, mumps, and rubella (MMR) vaccine. MMR vaccine includes live attenuated measles virus, which is detectable by PCR tests. No evidence exists of person-to-person transmission of measles vaccine virus, and illness does not typically result among immunocompetent persons...
March 28, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38547027/ceftriaxone-resistant-gonorrhea-china-2022
#19
JOURNAL ARTICLE
Xiaoyu Zhu, Yue Xi, Xiangdong Gong, Shaochun Chen
Gonorrhea is a widespread sexually transmitted infection; in 2022, China reported 96,313 cases of gonorrhea, making it the fourth most common notifiable infectious disease in the country after viral hepatitis, pulmonary tuberculosis, and syphilis. The rise in prevalence in antimicrobial-resistant strains, particularly the international spread of ceftriaxone-resistant clones, poses a formidable challenge to gonorrhea control. The China Gonococcal Resistance Surveillance Program (China-GRSP), established in 1987 and covering 19 of 34 provincial-level administrative units, continuously monitors gonococcal antimicrobial resistance...
March 28, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38547025/birth-prevalence-of-sickle-cell-disease-and-county-level-social-vulnerability-sickle-cell-data-collection-program-11-states-2016-2020
#20
JOURNAL ARTICLE
Mariam Kayle, Audrey L Blewer, Wei Pan, Jennifer A Rothman, Carri S Polick, Joshua Rivenbark, Elliott Fisher, Camila Reyes, John J Strouse, Shelby Weeks, Jay R Desai, Angela B Snyder, Mei Zhou, Ankit Sutaria, Jhaqueline Valle, Sophia S Horiuchi, Marci K Sontag, Joshua I Miller, Ashima Singh, Mahua Dasgupta, Isaac A Janson, Najibah Galadanci, Sarah L Reeves, Krista Latta, Isabel Hurden, Shamaree J Cromartie, Allison P Plaxco, Ayesha Mukhopadhyay, Matthew P Smeltzer, Mary Hulihan
Sickle cell disease (SCD) remains a public health priority in the United States because of its association with complex health needs, reduced life expectancy, lifelong disabilities, and high cost of care. A cross-sectional analysis was conducted to calculate the crude and race-specific birth prevalence for SCD using state newborn screening program records during 2016-2020 from 11 Sickle Cell Data Collection program states. The percentage distribution of birth mother residence within Social Vulnerability Index quartiles was derived...
March 28, 2024: MMWR. Morbidity and Mortality Weekly Report
journal
journal
20276
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.